FSC Wealth Advisors’s Novo Nordisk NVO Stock Holding History

FSC Wealth Advisors’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-526	Closed	-$42.6K	–	239
2023 Q2	$42.6K	Buy	+526	New	+$43K	0.04%	84

Other funds holding NVO

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

FSC Wealth Advisors's NVO Position: Q3 2023 in Review

FSC Wealth Advisors sold out of Novo Nordisk (NVO) in Q3 2023, closing a stake of 526 shares — an estimated $42.6K sold.

FSC Wealth Advisors first reported a position in NVO in Q2 2023 and held it in 1 quarter. The position peaked at $42.6K in Q2 2023. 1,307 funds tracked by Wall St. Rank hold NVO as of Q3 2023.

FSC Wealth Advisors reported no remaining Novo Nordisk position as of Q3 2023 after selling out during the quarter.
FSC Wealth Advisors sold 526 Novo Nordisk shares in Q3 2023, an estimated $42.6K.
FSC Wealth Advisors first reported a position in Novo Nordisk in Q2 2023 and held it in 1 quarter.
FSC Wealth Advisors's Novo Nordisk position peaked at $42.6K in Q2 2023.
1,307 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2023.

Based on FSC Wealth Advisors's 13F filing for Q3 2023, filed 24 Oct 2023.